Kushari Bowalgaha

543 total citations
8 papers, 455 citations indexed

About

Kushari Bowalgaha is a scholar working on Pharmacology, Molecular Biology and Oncology. According to data from OpenAlex, Kushari Bowalgaha has authored 8 papers receiving a total of 455 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pharmacology, 4 papers in Molecular Biology and 4 papers in Oncology. Recurrent topics in Kushari Bowalgaha's work include Pharmacogenetics and Drug Metabolism (7 papers), Drug Transport and Resistance Mechanisms (4 papers) and Cancer therapeutics and mechanisms (2 papers). Kushari Bowalgaha is often cited by papers focused on Pharmacogenetics and Drug Metabolism (7 papers), Drug Transport and Resistance Mechanisms (4 papers) and Cancer therapeutics and mechanisms (2 papers). Kushari Bowalgaha collaborates with scholars based in Australia, Sweden and Thailand. Kushari Bowalgaha's co-authors include John O. Miners, David J. Elliot, Kathleen Knights, Peter I. Mackenzie, Paweł Baranczewski, Stellan Swedmark, Leanne K. Winner, Moshe Finel, Wichittra Tassaneeyakul and Andrew Rowland and has published in prestigious journals such as British Journal of Clinical Pharmacology and Drug Metabolism and Disposition.

In The Last Decade

Kushari Bowalgaha

8 papers receiving 448 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kushari Bowalgaha Australia 8 301 168 141 73 61 8 455
Jianghua Tu China 13 243 0.8× 197 1.2× 167 1.2× 129 1.8× 54 0.9× 17 582
Shunsuke Iwano Japan 18 282 0.9× 187 1.1× 183 1.3× 54 0.7× 38 0.6× 26 580
Shuichi Fukuen Japan 6 226 0.8× 150 0.9× 121 0.9× 74 1.0× 27 0.4× 6 419
W. Brian United States 3 322 1.1× 251 1.5× 70 0.5× 120 1.6× 28 0.5× 5 431
E A Hodgson United States 8 272 0.9× 162 1.0× 111 0.8× 54 0.7× 31 0.5× 10 451
Yoshihiko Funae Japan 15 456 1.5× 212 1.3× 179 1.3× 89 1.2× 82 1.3× 21 812
Kazuya Ishida Japan 17 179 0.6× 318 1.9× 157 1.1× 166 2.3× 73 1.2× 50 703
Saki Yamano Japan 8 519 1.7× 288 1.7× 300 2.1× 111 1.5× 61 1.0× 23 844
R J Chenery United States 11 472 1.6× 253 1.5× 145 1.0× 64 0.9× 72 1.2× 14 681
Catherine Spire France 12 370 1.2× 193 1.1× 341 2.4× 75 1.0× 66 1.1× 14 850

Countries citing papers authored by Kushari Bowalgaha

Since Specialization
Citations

This map shows the geographic impact of Kushari Bowalgaha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kushari Bowalgaha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kushari Bowalgaha more than expected).

Fields of papers citing papers by Kushari Bowalgaha

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kushari Bowalgaha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kushari Bowalgaha. The network helps show where Kushari Bowalgaha may publish in the future.

Co-authorship network of co-authors of Kushari Bowalgaha

This figure shows the co-authorship network connecting the top 25 collaborators of Kushari Bowalgaha. A scholar is included among the top collaborators of Kushari Bowalgaha based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kushari Bowalgaha. Kushari Bowalgaha is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Tassaneeyakul, Wichittra, Andrew Rowland, David J. Elliot, et al.. (2012). Effect of Albumin on Human Liver Microsomal and Recombinant CYP1A2 Activities: Impact on In Vitro-In Vivo Extrapolation of Drug Clearance. Drug Metabolism and Disposition. 40(5). 982–989. 35 indexed citations
2.
Miners, John O., Kushari Bowalgaha, David J. Elliot, Paweł Baranczewski, & Kathleen Knights. (2011). Characterization of Niflumic Acid as a Selective Inhibitor of Human Liver Microsomal UDP-Glucuronosyltransferase 1A9: Application to the Reaction Phenotyping of Acetaminophen Glucuronidation. Drug Metabolism and Disposition. 39(4). 644–652. 94 indexed citations
3.
Knights, Kathleen, Kushari Bowalgaha, & John O. Miners. (2010). Spironolactone and Canrenone Inhibit UGT2B7-Catalyzed Human Liver and Kidney Microsomal Aldosterone 18β-Glucuronidation: A Potential Drug Interaction. Drug Metabolism and Disposition. 38(7). 1011–1014. 8 indexed citations
4.
Knights, Kathleen, Leanne K. Winner, David J. Elliot, Kushari Bowalgaha, & John O. Miners. (2009). Aldosterone glucuronidation by human liver and kidney microsomes and recombinant UDP‐glucuronosyltransferases: Inhibition by NSAIDs. British Journal of Clinical Pharmacology. 68(3). 402–412. 55 indexed citations
5.
Mackenzie, Peter I., et al.. (2009). Influence of N-Terminal Domain Histidine and Proline Residues on the Substrate Selectivities of Human UDP-Glucuronosyltransferase 1A1, 1A6, 1A9, 2B7, and 2B10. Drug Metabolism and Disposition. 37(9). 1948–1955. 48 indexed citations
6.
7.
Bowalgaha, Kushari, David J. Elliot, Peter I. Mackenzie, et al.. (2005). S‐Naproxen and desmethylnaproxen glucuronidation by human liver microsomes and recombinant human UDP‐glucuronosyltransferases (UGT): role of UGT2B7 in the elimination of naproxen. British Journal of Clinical Pharmacology. 60(4). 423–433. 89 indexed citations
8.
Bowalgaha, Kushari & John O. Miners. (2001). The glucuronidation of mycophenolic acid by human liver, kidney and jejunum microsomes. British Journal of Clinical Pharmacology. 52(5). 605–609. 85 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jianghua Tu Breakdown of academic impact, for papers by Shunsuke Iwano Breakdown of academic impact, for papers by Shuichi Fukuen Breakdown of academic impact, for papers by W. Brian Breakdown of academic impact, for papers by E A Hodgson Breakdown of academic impact, for papers by Yoshihiko Funae Breakdown of academic impact, for papers by Kazuya Ishida Breakdown of academic impact, for papers by Saki Yamano Breakdown of academic impact, for papers by R J Chenery Breakdown of academic impact, for papers by Catherine Spire
Rankless by CCL
2026